Hepatitis C antibody detection in dried blood spots. 1999

B McCarron, and R Fox, and K Wilson, and S Cameron, and J McMenamin, and G McGregor, and A Pithie, and D Goldberg
Department of Infectious Diseases and Tropical Medicine, Brownlee Centre, Gartnavel General Hospital, Glasgow, UK.

In the UK, there have been few studies of the seroprevalence of antibodies to hepatitis C virus (anti-HCV). As part of an ongoing prevalence study of HCV in injecting drug users, we have developed a technique for detecting anti-HCV in blood spots dried on filter paper using a commercially available assay. Subjects with and without serum anti-HCV were studied. The manufacturer's recommended cut-off (CO) for a positive anti-HCV result is kit-dependent, and therefore a ratio of test result (T) to kit CO was used to standardize results. T/CO values greater than 0.99 had a sensitivity of 100% and a specificity of 87.5% for anti-HCV detection. T/CO values greater than 1.99 had a sensitivity of 97.2% and a specificity of 100%. Hence, testing dried blood spots may be useful for detecting anti-HCV in epidemiological studies and as a diagnostic test in patients with poor peripheral venous access.

UI MeSH Term Description Entries
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D001800 Blood Specimen Collection The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc. Blood Specimen Collections,Collection, Blood Specimen,Collections, Blood Specimen,Specimen Collection, Blood,Specimen Collections, Blood
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D016036 Seroepidemiologic Studies EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases. Seroprevalence,Seroepidemiologic Study,Seroepidemiological Study,Studies, Seroepidemiologic,Study, Seroepidemiologic,Seroepidemiological Studies,Seroprevalences,Studies, Seroepidemiological,Study, Seroepidemiological
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D018937 Hepatitis C Antibodies Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins. Anti-HCV Antibodies,Anti-Hepatitis C Virus Antibodies,HCV Antibodies,Hepatitis C Virus Antibodies,Anti HCV Antibodies,Anti Hepatitis C Virus Antibodies

Related Publications

B McCarron, and R Fox, and K Wilson, and S Cameron, and J McMenamin, and G McGregor, and A Pithie, and D Goldberg
June 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
B McCarron, and R Fox, and K Wilson, and S Cameron, and J McMenamin, and G McGregor, and A Pithie, and D Goldberg
April 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
B McCarron, and R Fox, and K Wilson, and S Cameron, and J McMenamin, and G McGregor, and A Pithie, and D Goldberg
June 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
B McCarron, and R Fox, and K Wilson, and S Cameron, and J McMenamin, and G McGregor, and A Pithie, and D Goldberg
September 2019, Viruses,
B McCarron, and R Fox, and K Wilson, and S Cameron, and J McMenamin, and G McGregor, and A Pithie, and D Goldberg
October 2010, Scandinavian journal of clinical and laboratory investigation,
B McCarron, and R Fox, and K Wilson, and S Cameron, and J McMenamin, and G McGregor, and A Pithie, and D Goldberg
December 2017, Public health,
B McCarron, and R Fox, and K Wilson, and S Cameron, and J McMenamin, and G McGregor, and A Pithie, and D Goldberg
May 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
B McCarron, and R Fox, and K Wilson, and S Cameron, and J McMenamin, and G McGregor, and A Pithie, and D Goldberg
November 1997, Journal of virological methods,
B McCarron, and R Fox, and K Wilson, and S Cameron, and J McMenamin, and G McGregor, and A Pithie, and D Goldberg
April 2021, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
B McCarron, and R Fox, and K Wilson, and S Cameron, and J McMenamin, and G McGregor, and A Pithie, and D Goldberg
September 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Copied contents to your clipboard!